Investors Opt for P...
Health Care: Drugs
Watson Pharmaceuticals Inc. (WPI: NYSE)
$58.25 0.35 | 0.60%
02/09/12 - 04:02 PM ET
1.20M / 1.85M
Vol / Avg. Vol:58.00 / 57.90
Open / Prev. Close:57.35 - 58.29
Today's Range:53.73 - 73.35
52 Wk Range:-4.04%
Performance YTD:TheStreet Rating:
Portfolios with WPI
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- UserChapman
- Contributor10 S&P 500 Stocks For 2012
- Contributor10 Mid-Cap Stocks Analysts ...
- Usermine
- ProDiscovery Capital Management
- Contributor8 Health Care Buys Ahead of...
- UserBlue Star
- UserValueCruncher Undervalued T...
- UserPART 5 JPMorgan 28th Annual...
Latest WPI Headlines from TheStreet
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- 10 Top S&P 500 Stocks for 2012 01.05.12 | 10:01 am
- 10 Mid-Cap Stocks Analysts Love 12.15.11 | 02:12 pm
- Pfizer Faces Hazy Future Beyond Lipitor 12.09.11 | 02:12 pm
- Watson Pharmaceuticals Inc. (WPI): Today's Featured Health Care Loser 12.07.11 | 04:12 pm
- Watson Pharmaceuticals Inc. (WPI): Today's Featured Health Care Loser 11.30.11 | 05:11 pm
- Stocks to Watch: Goldman, Pfizer, Omnivision 11.30.11 | 07:11 am
- Watson Pharmaceuticals Inc. (WPI): Today's Featured Drugs Winner 11.17.11 | 04:11 pm
- 'Fast Money' Recap: Bullish Sentiment 11.07.11 | 08:11 pm
- Watson Pharmaceuticals Inc. (WPI): Today's Featured Health Care Loser 11.03.11 | 05:11 pm
Press Releases for WPI
- Watson To Host Conference Call And Webcast To Discuss Fourth Quarter 2011 Earnings - PR Newswire 01.30.12 | 04:01 pm
- Amgen And Watson Announce Collaboration To Develop And Commercialize Oncology Biosimilars - PR Newswire 12.19.11 | 04:12 pm
- Amgen And Watson Announce Collaboration To Develop And Commercialize Oncology Biosimilars - PR Newswire 12.19.11 | 04:12 pm
- Antares' Oxybutynin Gel Product Approved By FDA For The Treatment Of Overactive Bladder - PR Newswire 12.08.11 | 07:12 am
- Watson Confirms Exelon(R) Patent Challenge - PR Newswire 11.10.11 | 04:11 pm
- Watson Confirms Court Grants Preliminary Injunction Preventing Launch Of Generic LOVENOX® - PR Newswire 10.28.11 | 05:10 pm
- Watson Confirms Atelvia(TM) Patent Challenge - PR Newswire 10.17.11 | 04:10 pm
- Watson To Present At The Jefferies 2011 Global Healthcare Conference - PR Newswire 09.22.11 | 05:09 pm
- Perrigo Closes Acquisition Of Paddock Labs - PR Newswire 07.26.11 | 04:07 pm
- Watson Confirms JALYN⢠Patent Challenge - PR Newswire 07.22.11 | 05:07 pm
Partner Headlines for WPI
- A Baker's Dozen Of Top Value-Stocks For 2012: Part III - Seeking Alpha 02.03.12 | 08:02 am
- 5 Cheap Stocks That Could Jump Higher In 2012 - Seeking Alpha 01.27.12 | 05:01 pm
- Columbia Labs Plummet after Recommendation Denial by FDA - Benzinga 01.23.12 | 09:01 am
- FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - Benzinga 01.20.12 | 04:01 pm
- Watson Pharma and Columbia Labs Plunge on Proposed FDA Review - Benzinga 01.17.12 | 01:01 pm
- The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma, Dr. Reddy's and Novartis - Press Releases - Zacks 12.30.11 | 09:12 am
- Ring in Generics in 2012 and Beyond - Analyst Blog - Zacks 12.29.11 | 08:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
- Watson's Generic Launches Continue - Analyst Blog - Zacks 12.09.11 | 10:12 am
- Watson Launches Generic LoSEASONIQUE - Benzinga 12.07.11 | 04:12 pm
